Search NASA⌕ Search

SEARCH · Search NASA

Results for “RADIATION DOSE UNITS”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 records

SU-E-J-143: Short- and Near-Term Effects of Proton Therapy On Cerebral White Matter

Purpose: To assess early effects of proton therapy on the structural integrity of cerebral white matter in relation to the subsequent near-term development of such effects. Methods: Sixteen children (aged 2–19 years) with craniopharyngioma underwent proton therapy of 54 Cobalt Gray Equivalent (CGE) in a prospective therapeutic trial. Diffusion tensor imaging (DTI) was performed at baseline before proton therapy and every 3 months thereafter. Tract-based spatial statics analysis of DTI data was performed to derive the fractional anisotropy (FA) and radial diffusivity (RD) in 26 volumes of interest (VOIs). The dose distributions were spatially normalized to identify VOIs prone to high doses. The longitudinal percentage changes of the FA and RD in these VOIs at 3 and 12 months from the baseline were calculated, and their relationships were evaluated. Results: The average dose was highest to the cerebral peduncle (CP), corticospinal tract (CST) in the pons, pontine crossing tract (PCT), anterior/posterior limbs of the internal capsule (ALIC/PLIC), and genu of the corpus callosum (GCC). It ranged from 33.3 GCE (GCC) to 49.7 GCE (CP). A mild but statistically significant (P<0.05) decline of FA was observed 3 months after proton therapy in all VOIs except the PLIC and ranged from −1.7% (ALIC) to −2.8% (PCT). A significant increase of RD was found in the CP (3.5%) and ALIC (2.1%). The average longitudinal change from the baseline was reduced at 12 months for most VOIs. However, the standard deviation increased, indicating that the temporal pattern varied individually. The follow-up measurements at 3 and 12 months correlated for the CP, CST, PCT, and GCC (P < 0.04). Conclusion: DTI data suggest early (3 months) effects of proton therapy on microstructures in the white matter. The subsequent follow-up indicated individual variation of the changes, which was partly implied by the early effects.

60 APPLIED LIFE SCIENCES↗

Radiation damage of contact structures with diffusion barriers exposed to irradiation with {sup 60}Co{gamma}-ray photons

The effect of ionizing radiation of {sup 60}Co {gamma}-ray photons in the dose range 10{sup 4}-2 x 10{sup 9} rad on metal-semiconductor Au-ZrB{sub x}-AlGaN/GaN and Au-TiB{sub x}-Al-Ti-n-GaN contacts and Au-ZrB{sub x}-n-GaN Schottky diodes is examined. The contacts with the TiB{sub x} and ZrB{sub x} diffusion barriers do not degrade under the effect of ionizing radiation if the dose does not exceed 10{sup 8} rad. The Au-ZrB{sub x}-n-GaN Schottky diodes remain stable in the dose range 10{sup 4}-10{sup 6} rad. As the radiation dose is increased to {>=}10{sup 8} rad, the damage to the contact metallization increases and is accompanied by formation of through pores, which is conducive to accumulation of oxygen at the Au-ZrB{sub x}(TiB{sub x}) interfaces and to an increase in mass transport of atoms in contact-forming layers. In this case, irradiation-caused degradation of the Schottky diodes is observed. Possible mechanisms of radiation damage of contact structures with diffusion barriers are analyzed.

36 MATERIALS SCIENCE↗

Combined Proton and Photon Conformal Radiotherapy for Intracranial Atypical and Malignant Meningioma

Purpose: To evaluate retrospectively the efficacy of conformal fractionated radiotherapy combining proton and photon beams after primary surgery for treatment of atypical and malignant meningiomas. Patients and Methods: Between September 1999 and October 2006, 24 patients (12 male, 12 female) with histopathologically proven meningioma (atypical 19, malignant 5) received postoperative combined radiotherapy with a 201-MeV proton beam at the Centre Protontherapie d'Orsay and a high-energy photon beam. Six patients underwent gross total resection and 18 a subtotal resection. Median gross tumor volume and clinical target volume were 44.7 cm{sup 3} and 153.3 cm{sup 3}, respectively. Mean total irradiation dose was 65.01 CGE (cobalt gray equivalent), with a mean proton total dose of 34.05 CGE and a mean photon total dose 30.96 CGE. Results: The median (range) follow-up interval was 32.2 (1-72) months. The overall mean local relapse-free interval was 27.2 (10-50) months, 28.3 (10-50) months for atypical meningioma and 23 (13-33) months for malignant meningioma. Ten tumors recurred locally. One-, 2-, 3-, 4-, 5-, and 8- year local control rates for the entire group of patients were 82.9% {+-} 7.8%, 82.9% {+-} 7.8%, 61.3% {+-} 11%, 61.3% {+-} 11%, 46.7% {+-} 12.3%, and 46.7% {+-} 12.3%, respectively. One-, 2-, 3-, 4-, 5-, and 8- year overall survival rates were 100%, 95.5% {+-} 4.4%, 80.4% {+-} 8.8%, 65.3% {+-} 10.6%, 53.2% {+-} 11.6%, and 42.6% {+-} 13%, respectively. Survival was significantly associated with total dose. There was no acute morbidity of radiotherapy. One patient developed radiation necrosis 16 months after treatment. Conclusions: Postoperative combination of conformal radiotherapy with protons and photons for atypical and malignant meningiomas is a well-tolerated treatment producing long-term tumor stabilization.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Proton Radiotherapy for Pediatric Bladder/Prostate Rhabdomyosarcoma: Clinical Outcomes and Dosimetry Compared to Intensity-Modulated Radiation Therapy

Purpose: In this study, we report the clinical outcomes of 7 children with bladder/prostate rhabdomyosarcoma (RMS) treated with proton radiation and compare proton treatment plans with matched intensity-modulated radiation therapy (IMRT) plans, with an emphasis on dose savings to reproductive and skeletal structures. Methods and Materials: Follow-up consisted of scheduled clinic appointments at our institution or direct communication with the treating physicians for referred patients. Each proton radiotherapy plan used for treatment was directly compared to an IMRT plan generated for the study. Clinical target volumes and normal tissue volumes were held constant to facilitate dosimetric comparisons. Each plan was optimized for target coverage and normal tissue sparing. Results: Seven male patients were treated with proton radiotherapy for bladder/prostate RMS at the Massachusetts General Hospital between 2002 and 2008. Median age at treatment was 30 months (11-70 months). Median follow-up was 27 months (10-90 months). Four patients underwent a gross total resection prior to radiation, and all patients received concurrent chemotherapy. Radiation doses ranged from 36 cobalt Gray equivalent (CGE) to 50.4 CGE. Five of 7 patients were without evidence of disease and with intact bladders at study completion. Target volume dosimetry was equivalent between the two modalities for all 7 patients. Proton radiotherapy led to a significant decrease in mean organ dose to the bladder (25.1 CGE vs. 33.2 Gy; p = 0.03), testes (0.0 CGE vs. 0.6 Gy; p = 0.016), femoral heads (1.6 CGE vs. 10.6 Gy; p = 0.016), growth plates (21.7 CGE vs. 32.4 Gy; p = 0.016), and pelvic bones (8.8 CGE vs. 13.5 Gy; p = 0.016) compared to IMRT. Conclusions: This study provides evidence of significant dose savings to normal structures with proton radiotherapy compared to IMRT and is well tolerated in this patient population. The long-term impact of these reduced doses can be tested in future studies incorporating extended follow-up, objective outcome measures, and quality-of-life analyses.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Early Outcomes From Three Prospective Trials of Image-Guided Proton Therapy for Prostate Cancer

Purpose: To report early outcomes with image-guided proton therapy for prostate cancer. Methods and Materials: We accrued 211 prostate cancer patients on prospective Institutional Review Board-approved trials of 78 cobalt gray equivalent (CGE) in 39 fractions for low-risk disease, dose escalation from 78 to 82 CGE for intermediate-risk disease, and 78 CGE with concomitant docetaxel followed by androgen deprivation for high-risk disease. Minimum follow-up was 2 years. Results: One intermediate-risk patient and 2 high-risk patients had disease progression. Pretreatment genitourinary (GU) symptom management was required in 38% of patients. A cumulative 88 (42%) patients required posttreatment GU symptom management. Four transient Grade 3 GU toxicities occurred, all among patients requiring pretreatment GU symptom management. Multivariate analysis showed correlation between posttreatment GU 2+ symptoms and pretreatment GU symptom management (p < 0.0001) and age (p = 0.0048). Only 1 Grade 3+ gastrointestinal (GI) symptom occurred. The prevalence of Grade 2+ GI symptoms was 0 (0%), 10 (5%), 12 (6%), and 8 (4%) at 6, 12, 18, and 24 months, with a cumulative incidence of 20 (10%) patients at 2 years after proton therapy. Univariate and multivariate analyses showed significant correlation between Grade 2+ rectal bleeding and proctitis and the percentage of rectal wall (rectum) receiving doses ranging from 40 CGE (10 CGE) to 80 CGE. Conclusions: Early outcomes with image-guided proton therapy suggest high efficacy and minimal toxicity with only 1.9% Grade 3 GU symptoms and <0.5% Grade 3 GI toxicities.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Proton Radiotherapy for Parameningeal Rhabdomyosarcoma: Clinical Outcomes and Late Effects

Purpose: To report the clinical outcome and late side effect profile of proton radiotherapy in the treatment of children with parameningeal rhabdomyosarcoma (PM-RMS). Methods and Materials: Seventeen consecutive children with PM-RMS were treated with proton radiotherapy at Massachusetts General Hospital between 1996 and 2005. We reviewed the medical records of all patients and asked referring physicians to report specific side effects of interest. Results: Median patient age at diagnosis was 3.4 years (range, 0.4-17.6). Embryonal (n = 11), alveolar (n = 4), and undifferentiated (n = 2) histologies were represented. Ten patients (59%) had intracranial extension. Median prescribed dose was 50.4 cobalt gray equivalents (GyRBE) (range, 50.4-56.0 GyRBE) delivered in 1.8-2.0-GyRBE daily fractions. Median follow-up was 5.0 years for survivors. The 5-year failure-free survival estimate was 59% (95% confidence interval, 33-79%), and overall survival estimate was 64% (95% confidence interval, 37-82%). Among the 7 patients who failed, sites of first recurrence were local only (n = 2), regional only (n = 2), distant only (n = 2), and local and distant (n = 1). Late effects related to proton radiotherapy in the 10 recurrence-free patients (median follow-up, 5 years) include failure to maintain height velocity (n = 3), endocrinopathies (n = 2), mild facial hypoplasia (n = 7), failure of permanent tooth eruption (n = 3), dental caries (n = 5), and chronic nasal/sinus congestion (n = 2). Conclusions: Proton radiotherapy for patients with PM-RMS yields tumor control and survival comparable to that in historical controls with similar poor prognostic factors. Furthermore, rates of late effects from proton radiotherapy compare favorably to published reports of photon-treated cohorts.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Radiotherapy Doses of 80 Gy and Higher Are Associated With Lower Mortality in Men With Gleason Score 8 to 10 Prostate Cancer

Purpose: Men with Gleason score (GS) 8-10 prostate cancer (PCa) are assumed to have a high risk of micrometastatic disease at presentation. However, local failure is also a major problem. We sought to establish the importance of more aggressive local radiotherapy (RT) to {>=}80 Gy. Methods and Materials: There were 226 men treated consecutively with RT {+-} ADT from 1988 to 2002 for GS 8-10 PCa. Conventional, three-dimensional conformal or intensity-modulated (IM) RT was used. Radiation dose was divided into three groups: (1) <75 Gy (n = 50); (2) 75-79.9 Gy (n = 60); or (3) {>=}80 Gy (n = 116). The endpoints examined included biochemical failure (BF; nadir + 2 definition), distant metastasis (DM), cause-specific mortality, and overall mortality (OM). Results: Median follow-up was 66, 71, and 58 months for Groups 1, 2, and 3. On Fine and Gray's competing risk regression analysis, significant predictors of reduced BF were RT dose {>=}80 Gy (p = 0.011) and androgen deprivation therapy duration {>=}24 months (p = 0.033). In a similar model of DM, only RT dose {>=}80 Gy was significant (p = 0.007). On Cox regression analysis, significant predictors of reduced OM were RT dose {>=}80 Gy (p = 0.035) and T category (T3/4 vs. T1, p = 0.041). Dose was not a significant determinant of cause-specific mortality. Results for RT dose were similar in a model with RT dose and ADT duration as continuous variables. Conclusion: The results indicate that RT dose escalation to {>=}80 Gy is associated with lower risks of BF, DM, and OM in men with GS 8-10 PCa, independently of androgen deprivation therapy.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Toxicity After Central versus Peripheral Lung Stereotactic Body Radiation Therapy: A Propensity Score Matched-Pair Analysis

Purpose: To compare toxicity after stereotactic body radiation therapy (SBRT) for “central” tumors—within 2 cm of the proximal bronchial tree or with planning tumor volume (PTV) touching mediastinum—versus noncentral (“peripheral”) lung tumors. Methods and Materials: From November 2005 to January 2011, 229 tumors (110 central, 119 peripheral; T1-3N0M0 non–small-cell lung cancer and limited lung metastases) in 196 consecutive patients followed prospectively at a single institution received moderate-dose SBRT (48-60 Gy in 4-5 fractions [biologic effective dose=100-132 Gy, α/β=10]) using 4-dimensional planning, online image-guided radiation therapy, and institutional dose constraints. Clinical adverse events (AEs) were graded prospectively at clinical and radiographic follow-up using Common Terminology Criteria for Adverse Events version 3.0. Pulmonary function test (PFT) decline was graded as 2 (25%-49.9% decline), 3 (50.0%-74.9% decline), or 4 (≥75.0% decline). Central/peripheral location was assessed retrospectively on planning CT scans. Groups were compared after propensity score matching. Characteristics were compared with χ{sup 2} and 2-tailed t tests, adverse events with χ{sup 2} test-for-trend, and cumulative incidence using competing risks analysis (Gray's test). Results: With 79 central and 79 peripheral tumors matched, no differences in AEs were observed after 17 months median follow-up. Two-year cumulative incidences of grade ≥2 pain, musculoskeletal, pulmonary, and skin AEs were 14%, 5%, 6%, and 10% (central) versus 19%, 10%, 10%, and 3% (peripheral), respectively (P=.31, .38, .70, and .09). Grade ≥2 cardiovascular, gastrointestinal, and central nervous system AEs were rare (<1%). Two-year incidences of grade ≥2 clinical AEs (28% vs 25%, P=.79), grade ≥2 PFT decline (36% vs 34%, P=.94), grade ≥3 clinical AEs (3% vs 7%, P=.48), and grade ≥3 PFT decline (0 vs 10%, P=.11) were similar for central versus peripheral tumors, respectively. Pooled 2-year incidences of grades 4 and 5 AEs were <1% and 0%, respectively, in both the prematched and matched groups. Conclusion: Moderate-dose SBRT with these techniques yields a similarly safe toxicity profile for both central and peripheral lung tumors.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Risks of secondary malignancies with heterotopic bone radiation therapy for patients younger than 40 years

Heterotopic ossification (HO) of the bone is defined as a benign condition in which abnormal bone formation occurs in soft tissue. One of the most common prophylactic treatments for HO is radiation therapy (RT). This study retrospectively reviewed 20 patients younger than the age of 40 who received radiation to prevent HO in a single fraction of 7 Gray. The purpose of this study is to assess the risk of a second malignancy in these patients by recreating their treatment fields and contouring organs at risk to estimate the radiation dose absorbed by normal tissues outside the radiation treatment field. Diagnostic computed tomography (CT) scans for each patient were used to recreate treatment fields and to calculate dose to structures of interest. The distance from the field edge to each structure and its depth was recorded. Dose measurements in a water phantom were performed for the range of depths, distances, and field sizes used in the actual treatment plans. Computer-generated doses were compared to estimates based on measurement. The structure dose recorded was the higher dose generated between the 2 methods. Scatter dose was recorded to the rectum, bladder, sigmoid colon, small bowel, ovaries and utero-cervix in female patients, and prostate and gonads in male patients. In some patients, there is considerable dose received by certain organs from scatter because of their proximity to the radiation field. The average dose to the ovarian region was 4.125 Gy with a range of 1.085 to 6.228 Gy. The risk estimate for these patients ranged from 0.16% to 0.93%. The average total lifetime risk estimate for the bladder in all patients is 0.22% and the average total lifetime risk estimate for the remainder organs in all patients is 1.25%. In conclusions, proper shielding created from multileaf collimators (MLCs), blocks, and shields should always be used when possible.

61 RADIATION PROTECTION AND DOSIMETRY↗

SU-E-J-122: Detecting Treatment-Induced Metabolic Abnormalities in Craniopharyngioma Patients Undergoing Surgery and Proton Therapy

Purpose: To identify treatment-induced defects in the brain of children with craniopharyngioma receiving surgery and proton therapy using fluorodeoxyglucose positron emission tomography (FDG PET). Methods: Forty seven patients were enrolled on a clinical trial for craniopharyngioma with serial imaging and functional evaluations. Proton therapy was delivered using the double-scattered beams with a prescribed dose of 54 Cobalt Gray Equivalent. FDG tracer uptake in each of 63 anatomical regions was computed after warping PET images to a 3D reference template in Talairach coordinates. Regional uptake was deemed significantly low or high if exceeding two standard deviations of normal population from the mean. For establishing the normal ranges, 132 children aged 1–20 years with noncentral nervous system related diseases and normal-appearing cerebral PET scans were analyzed. Age- and gender-dependent regional uptake models were developed by linear regression and confidence intervals were calculated. Results: Most common PET abnormality before proton therapy was significantly low uptake in the frontal lobe, the occipital lobe (particularly in cuneus), the medial and ventral temporal lobe, cingulate gyrus, caudate nuclei, and thalamus. They were related to injury from surgical corridors, tumor mass effect, insertion of a ventricular catheter, and the placement of an Ommaya reservoir. Surprisingly a significantly high uptake was observed in temporal gyri and the parietal lobe. In 13 patients who already completed 18-month PET scans, metabolic abnormalities improved in 11 patients from baseline. One patient had persistent abnormalities. Only one revealed new uptake abnormalities in thalamus, brainstem, cerebellum, and insula. Conclusion: Postoperative FDG PET of craniopharyngioma patients revealed metabolic abnormalities in specific regions of the brain. Proton therapy did not appear to exacerbate these surgery- and tumor-induced defects. In patients with persistent and new abnormalities, continued investigation on clinical symptoms and cognitive outcomes is ongoing to establish the association and predictive values of metabolic imaging.

60 APPLIED LIFE SCIENCES↗

Electrical conductivity of {gamma}-irradiated crystals of La{sub 0.95}Ba{sub 0.05}F{sub 2.95} superionic conductor

The electrical conductivity of single crystals of the La{sub 0.95}Ba{sub 0.05}F{sub 2.95} superionic conductor subjected to irradiation by {gamma} quanta (source {gamma}-{sup 60}Co, dose 2 Multiplication-Sign 10{sup 6} rad) has been investigated. It is shown that the radiation defects do not have a great effect on the ionic conductivity of nonstoichiometric La{sub 0.95}Ba{sub 0.05}F{sub 2.95} crystals, which is caused by the heterovalent replacements of La{sup 3+} cations with Ba{sup 2+} cations.

75 CONDENSED MATTER PHYSICS, SUPERCONDUCTIVITY AND↗

Radiation-induced surface degradation of GaAs and high electron mobility transistor structures

Transistor heterostructures with high-carrier-mobility have been studied. It is shown that, as the {gamma}-irradiation dose {Phi} increases, their degradation occurs in the following sequence. (i) At {Phi} < 10{sup 7} rad, the GaAs surface layer is damaged to a depth of 10 nm due to a >0.2-eV decrease in the diffusion energy of intrinsic defects and, probably, atmospheric oxygen. (ii) At {Phi} > 10{sup 7} rad, highly structurally disordered regions larger than 1 {mu}m are formed near microscopic defects or dislocations. (iii) At {Phi} > 10{sup 8} rad, there occurs degradation of the internal AlGaAs/InGaAs/GaAs interfaces and the working channel. An effective method for studying the degradation processes in heterostructures is to employ a set of structural diagnostic methods to analyze processes of radiation-induced and aging degradation, in combination with theoretical simulation of the occurring processes.

36 MATERIALS SCIENCE↗

Repackaging of High Fissile TRU Waste at the Transuranic Waste Processing Center - 13240

Twenty-six drums of high fissile transuranic (TRU) waste from Oak Ridge National Laboratory (ORNL) operations were declared waste in the mid-1980's and placed in storage with the legacy TRU waste inventory for future treatment and disposal at the Waste Isolation Pilot Plant (WIPP). Repackaging and treatment of the waste at the TRU Waste Packaging Center (TWPC) will require the installation of additional equipment and capabilities to address the hazards for handling and repackaging the waste compared to typical Contact Handled (CH) TRU waste that is processed at the TWPC, including potential hydrogen accumulation in legacy 6M/2R packaging configurations, potential presence of reactive plutonium hydrides, and significant low energy gamma radiation dose rates. All of the waste is anticipated to be repackaged at the TWPC and certified for disposal at WIPP. The waste is currently packaged in multiple layers of containers which presents additional challenges for repackaging activities due to the potential for the accumulation of hydrogen gas in the container headspace in quantities than could exceed the Lower Flammability Limit (LFL). The outer container for each waste package is a stainless steel 0.21 m{sup 3} (55-gal) drum which contains either a 0.04 m{sup 3} or 0.06 m{sup 3} (10-gal or 15-gal) 6M drum. The inner 2R container in each 6M drum is ∼12 cm (5 in) outside diameter x 30-36 cm (12-14 in) long and is considered to be a > 4 liter sealed container relative to TRU waste packaging criteria. Inside the 2R containers are multiple configurations of food pack cans, pipe nipples, and welded capsules. The waste contains significant quantities of high burn-up plutonium oxides and metals with a heavy weight percentage of higher atomic mass isotopes and the subsequent in-growth of significant quantities of americium. Significant low energy gamma radiation is expected to be present due to the americium in-growth. Radiation dose rates on inner containers are estimated to be 1-3 mSv/hr (100-300 mrem/hr) with an unshielded dose rate on the waste itself of over 10 mSv/hr (1 rem/hr). Additional equipment to be installed at the TWPC will include a new perma-con enclosure and a shielded/inert glovebox in the process building to repackage and stabilize the waste. All of the waste will be repackaged into Standard Pipe Overpacks. Most of the waste (21 of the 26 drums) is expected to be repackaged at the food-pack can level (i.e. the food-pack cans will not be opened). Five of the incoming waste containers are expected to be repackaged at the primary waste level. Three of the containers exceed the 200 gram Pu-239 Fissile Gram Equivalent (FGE) limit for the Standard Pipe Overpack. These three containers will be repackaged down to the primary waste level and divided into eight Standard Pipe Overpacks for shipment to WIPP. Two containers must be stabilized to eliminate any reactive plutonium hydrides that may be present. These containers will be opened in the inert, shielded glovebox, and the remaining corroded plutonium metal converted to a stable oxide form by using a 600 deg. C tube furnace with controlled oxygen feed in a helium carrier gas. The stabilized waste will then be packaged into two Standard Pipe Overpacks. Design and build out activities for the additional repackaging capabilities at the TWPC are scheduled to begin in Fiscal Year 2013 with repackaging, stabilization, and certification activities scheduled to begin in Fiscal Year 2014. Following repackaging and stabilization activities, the Standard Pipe Overpacks will be certified for disposal at WIPP utilizing Non-Destructive Examination (NDE) to verify the absence of prohibited items and Non-Destructive Assay (NDA) to verify the isotopic content under the TWPC WIPP certification program implemented by the Central Characterization Project (CCP). (authors)

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

Portland cement paste behaviour under gamma radiation field in geological repository - 15272

The Radioactive Waste Management Laboratory at the Nuclear and Energy Research Institute in Sao Paulo, Brazil (IPEN-CNEN-SP), is developing the concept of a repository for disposition of disused sealed radioactive sources in a deep borehole in which cement paste is intended to be used as a backfill between the steel casing and the geological formation around the borehole. The cement paste is intended to function as structural material, a blockage against the transport of water between the different strata of the geological setting, and as an additional barrier against the migration of radionuclides. The assessment of the cement paste behaviour in long term is necessary to increase the confidence that the material will perform as required during the service life of the facility. Under radiation, pore water present in cement paste suffers radiolysis and some products can be highly reactive, as electrons and hydroxyl radicals and hydrogen peroxide. These radiolysis products will interact with cement paste and its hydration products, forming a wide range of compounds. Previous work focused on assessing the synergic effects of radiation and environmental conditions, like higher temperature and aggressive groundwater chemicals, on cement paste. Examination of samples detected small differences in mineralogy and microstructure. However, the radiation dose to which samples were exposed (400 kGy) was only a fraction of the expected accumulated dose in cement paste until complete decay of some sealed sources in the repository. Therefore, several thousand kilo-grays must be tested the possibility of radiation to alter cement mineralogy and, as a consequence, its durability The objective of this research is to evaluate the changes in mineralogy and microstructure of irradiated cement paste specimens, in an attempt to establish a relationship between irradiation and durability. Cubic Portland cement specimens were casted and exposed to the gamma radiation of a 60 Co multipurpose irradiator, at IPEN-CNEN/SP. The effects of doses between 1000 kGy and 4000 kGy are evaluated by X-Ray Diffraction, Scanning Electron Microscopy, X-ray micro tomography, neutrongraphy and neutron scattering. This report presents the changes in cement paste mineralogy when samples are examined by XRD. Results indicate that durability can be affected because of the observed changes. Results are expected to indicate the induced changes in cement paste under high radiation doses and to provide hints on its behaviour in the long-term and service-life. The results can be used in safety analysis for deep geological repositories that use cement based materials as engineered barriers. (authors)

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗

Radioactive contamination from 1920-50's at an urban site of the New York City and interim remedial action - 15630

The former Wolff-Alport Chemical Company operated at the location in densely populated urban area in Queens, New York, between 1920 to about 1954. The company imported, stored on-site and processed monazite sand ores from the Belgium Congo. The extracted refined products enriched in rare-earth metals were sold on the commercial market. The process residues, rich in thorium and its progeny, were originally disposed of directly to the city sewer line and probably on-site also. The site's buildings are currently occupied by the auto shops, corner delicatessen store, light construction company, ice maker/distributor, and two residential apartments. Preliminary site investigations found multiple areas with elevated levels of direct gamma radiation with the maximum reported rates of 22 micro-sievert/hour (2.2 milli-rem/hour) at surface level and 40 micro-sievert/hour (4 milli-rem/hour) inside sewer manhole access. The thoron (Rn-220) gas air concentration in outdoor areas was reported reaching 13.5 kBq/m{sup 3} (366 pCi/L) and the radon (Rn-222) gas air concentrations was reported exceeding 148 Bq/ m{sup 3} (4 pCi/L) in some buildings. The dose assessments indicated that, under realistic scenarios, some members of the public were likely to receive the radiation exposure from this contamination in excess of the New York City and Nuclear Regulatory Commission general public radiation dose limit of 1 milli-sievert /yr (100 milli-rem/yr). The interim remedial action was planned and conducted by the U.S. Environmental Protection Agency (U.S. EPA) Region 2 in close cooperation with the New York City and New York State in 2012-13. The purpose of the action was to take necessary interim measures to reduce annual public dose below limit of 1 milli-sievert/yr (100 milli-rem/yr) and reduce radon gas concentration levels in impacted indoor spaces below U.S. EPA Action Level for residencies of 148 Bq/ m{sup 3} (4 pCi/L). In order to achieve these goals, the following actions were taken: detailed radiological and occupancy surveys; development of realistic exposure scenarios; dose assessments; installation of the fence and gates around the 'backyard' portion of the site; vegetation removal; development and detailed assessment of the radiation shielding options; application of the multilayer radiation shielding in some buildings, portions of the sidewalk and unpaved areas; mitigation of radon/thoron gas entry point; and installation of the radon mitigation system in one of the buildings. The preliminary post-action analyses indicated that the action goal would likely be achieved. The interim remedial action was conducted in a tight urban setting; it has significantly reduced public health risk from radiation without closure of businesses that continued operating within the site perimeter. (authors)

61 RADIATION PROTECTION AND DOSIMETRY↗

White and Gray Matter Abnormalities After Cranial Radiation in Children and Mice

Purpose: Pediatric patients treated with cranial radiation are at high risk of developing lasting cognitive impairments. We sought to identify anatomical changes in both gray matter (GM) and white matter (WM) in radiation-treated patients and in mice, in which the effect of radiation can be isolated from other factors, the time course of anatomical change can be established, and the effect of treatment age can be more fully characterized. Anatomical results were compared between species. Methods and Materials: Patients were imaged with T{sub 1}-weighted magnetic resonance imaging (MRI) after radiation treatment. Nineteen radiation-treated patients were divided into groups of 7 years of age and younger (7−) and 8 years and older (8+) and were compared to 41 controls. C57BL6 mice were treated with radiation (n=52) or sham treated (n=52) between postnatal days 16 and 36 and then assessed with in vivo and/or ex vivo MRI. In both cases, measurements of WM and GM volume, cortical thickness, area and volume, and hippocampal volume were compared between groups. Results: WM volume was significantly decreased following treatment in 7− and 8+ treatment groups. GM volume was unchanged overall, but cortical thickness was slightly increased in the 7− group. Results in mice mostly mirrored these changes and provided a time course of change, showing early volume loss and normal growth. Hippocampal volume showed a decreasing trend with age in patients, an effect not observed in the mouse hippocampus but present in the olfactory bulb. Conclusions: Changes in mice treated with cranial radiation are similar to those in humans, including significant WM and GM alterations. Because mice did not receive any other treatment, the similarity across species supports the expectation that radiation is causative and suggests mice provide a representative model for studying impaired brain development after cranial radiation and testing novel treatments.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Validating a Local Failure Risk Stratification for Use in Prospective Studies of Adjuvant Radiation Therapy for Bladder Cancer

Purpose: To inform prospective trials of adjuvant radiation therapy (adj-RT) for bladder cancer after radical cystectomy, a locoregional failure (LF) risk stratification was proposed. This stratification was developed and validated using surgical databases that may not reflect the outcomes expected in prospective trials. Our purpose was to assess sources of bias that may affect the stratification model's validity or alter the LF risk estimates for each subgroup: time bias due to evolving surgical techniques; trial accrual bias due to inclusion of patients who would be ineligible for adj-RT trials because of early disease progression, death, or loss to follow-up shortly after cystectomy; bias due to different statistical methods to estimate LF; and subgrouping bias due to different definitions of the LF subgroups. Methods and Materials: The LF risk stratification was developed using a single-institution cohort (n=442, 1990-2008) and the multi-institutional SWOG 8710 cohort (n=264, 1987-1998) treated with radical cystectomy with or without chemotherapy. We evaluated the sensitivity of the stratification to sources of bias using Fine-Gray regression and Kaplan-Meier analyses. Results: Year of radical cystectomy was not associated with LF risk on univariate or multivariate analysis after controlling for risk group. By use of more stringent inclusion criteria, 26 SWOG patients (10%) and 60 patients from the single-institution cohort (14%) were excluded. Analysis of the remaining patients confirmed 3 subgroups with significantly different LF risks with 3-year rates of 7%, 17%, and 36%, respectively (P<.01), nearly identical to the rates without correcting for trial accrual bias. Kaplan-Meier techniques estimated higher subgroup LF rates than competing risk analysis. The subgroup definitions used in the NRG-GU001 adj-RT trial were validated. Conclusions: These sources of bias did not invalidate the LF risk stratification or substantially change the model's LF estimates.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Chloride substitution in sodium borohydride

The dissolution of sodium chloride and sodium borohydride into each other resulting in formation of solid solutions of composition Na(BH{sub 4}){sub 1-x}Cl{sub x} is studied. The dissolution reaction is facilitated by two methods: ball milling or combination of ball milling and annealing at 300 deg. C for three days of NaBH{sub 4}-NaCl samples in molar ratios of 0.5:0.5 and 0.75:0.25. The degree of dissolution is studied by Rietveld refinement of synchrotron radiation powder X-ray diffraction (SR-PXD) data. The results show that dissolution of 10 mol% NaCl into NaBH{sub 4}, forming Na(BH{sub 4}){sub 0.9}Cl{sub 0.1}, takes place during ball milling. A higher degree of dissolution of NaCl in NaBH{sub 4} is obtained by annealing resulting in solid solutions containing up to 57 mol% NaCl, i.e. Na(BH{sub 4}){sub 0.43}Cl{sub 0.57}. In addition, annealing results in dissolution of 10-20 mol% NaBH{sub 4} into NaCl. The mechanism of the dissolution during annealing and the decomposition pathway of the solid solutions are studied by in situ SR-PXD. Furthermore, the stability upon hydrogen release and uptake were studied by Sieverts measurements. - Graphical Abstract: Dissolution of sodium chloride and sodium borohydride into each other resulting in formation of solid solutions of composition Na(BH{sub 4}){sub 1-x}Cl{sub x} is studied. Dissolution is facilitated by two methods: ball milling or annealing at 300 deg. C for three days of NaBH{sub 4}-NaCl samples. Sample compositions and dissolution mechanism are studied by Rietveld refinement of synchrotron radiation powder X-ray diffraction data. Highlights: > Studies of dissolution of sodium chloride and sodium borohydride into each other. > Solid state diffusion facilitated by mechanical and thermal treatments. > Dissolution is more efficiently induced by heating than by mechanical treatment. > Mechanism for dissolution studied by Rietveld refinement of in situ SR-PXD data.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗